Jieqiong Chen

Jieqiong Chen

Auto-generated profile, based on publicly available information

Jieqiong Chen

Department of Ophthalmology, Shanghai General Hospital (Shanghai First People’s Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
YQYiran Qiu
Yiran Qiu
SKShouyu Ke
Shouyu Ke
JCJieqiong Chen
Jieqiong Chen
ZQZhizhen Qin
Zhizhen Qin
WZWenle Zhang
Wenle Zhang
斌李斌 李
斌 李
FOXP3+ regulatory T (Treg) cells play critical roles in establishing the immunosuppressive tumour microenvironment, which is achieved and dynamically maintained with the contribution of various stromal and immune cell subsets. However, the dynamics of non-lymphoid FOXP3+ Treg cells and the mutual regulation of Treg cells and other cell types in solid tumour microenvironment remains largely unclear. In this review, we summarize the latest findings on the dynamic connections and reciprocal regulations of non-lymphoid Treg cell subsets in accordance with well-established and new emerging hallmarks of cancer, especially on the immune escape of tumour cells in solid tumours. Our comprehension of the interplay between FOXP3+ Treg cells and key hallmarks of cancer may provide new insights into the development of next-generation engineered T cell-based immune treatments for solid tumours.

22 September 2022 in Ophthalmology
Verified
Journal Article
Open access
QBQiyu Bo
Qiyu Bo
MZMin Zhang
Min Zhang
JCJieqiong Chen
Jieqiong Chen
HJHuixun Jia
Huixun Jia
MSMengxi Shen
Mengxi Shen
Xiaodong SunXiaodong Sun
Xiaodong Sun
To investigate the characteristics of the branching vascular network (BVN) and polypoidal lesions in polypoidal choroidal vasculopathy (PCV) to determine near-term indicators that may predict exudative recurrence. Retrospective cohort study. Patients with PCV receiving anti-vascular endothelial growth factor (VEGF) monotherapy or anti-VEGF plus photodynamic therapy were followed for at least 1 year using swept-source OCT angiography (SS-OCTA) imaging. Patients were divided into 2 groups based on whether exudative recurrence occurred during follow-up. Multiple parameters were collected and compared between the 2 groups, such as age, gender, visual acuity, number of polypoidal lesions, lesion area at the first SS-OCTA visit, and total lesion area change from the first SS-OCTA visit to the last SS-OCTA visit. To evaluate the association between SS-OCTA imaging-based risk factors and the exudative recurrences, imaging features associated with PCV such as BVN growth and polypoidal lesion progression (enlargement, new appearance, and reappearance) at each follow-up visit were analyzed. The time intervals from the nonexudative visit with lesion progression to the corresponding exudative recurrence visit were documented to explore their association with exudative recurrences. Cox regression and logistic regression analyses were used. Association between BVN growth and polypoidal lesion progression with exudative recurrence. Thirty-one eyes of 31 patients (61% men) were included. Sixteen eyes had no recurrence of exudation, and 15 eyes had recurrence during follow-up. The average follow-up duration was 20.55 ± 6.86 months (range, 12-36 months). Overall, the recurrence group had worse best-corrected visual acuity (P = 0.019) and a greater increase in lesion area (P = 0.010). Logistical regression analysis showed that polypoidal lesion progression, including new appearance, enlargement, and reappearance of polypoidal lesions, was associated with exudative recurrences within 3 months (odds ratio, 26.67, 95% confidence interval, 3.77-188.54, P = 0.001). Growth of nonexudative BVN and progression of polypoidal lesions were found to be lesion characteristics associated with exudative recurrences, and progression of polypoidal lesions might serve as a stand-alone indicator for the near-term onset of exudation. In PCV, more frequent follow-up visits are recommended when polypoidal lesions show progression.

9 March 2023 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
XZXiaohuan Zhao
Xiaohuan Zhao
QBQiyu Bo
Qiyu Bo
JSJunran Sun
Junran Sun
JCJieqiong Chen
Jieqiong Chen
TLTong Li
Tong Li
Xiaodong SunXiaodong Sun
Xiaodong Sun
OBJECTIVES: This study evaluated the association between obesity and glaucoma in middle-aged and older people. A population-based retrospective cohort study was conducted using data from the China Health and Retirement Longitudinal Study.METHODS: Glaucoma was assessed via self-reports. Multivariate logistic regression analysis and a Cox proportional hazards model were used to assess the relationship between obesity and glaucoma risk.RESULTS: Older males living in urban areas who were single, smokers, and non-drinkers were found to have a significantly higher incidence of glaucoma (all p<0.05). Diabetes, hypertension, and kidney disease were also associated with higher glaucoma risk, while dyslipidemia was associated with lower risk (all p<0.05). After the model was adjusted for demographic, socioeconomic, and health-related variables, obesity was significantly associated with a 10.2% decrease in glaucoma risk according to the Cox proportional hazards model (hazard ratio, 0.90; 95% confidence interval [CI], 0.83 to 0.97) and an 11.8% risk reduction in the multivariate logistic regression analysis (odds ratio, 0.88; 95% CI, 0.80 to 0.97). A further subgroup analysis showed that obesity was associated with a reduced risk of glaucoma in people living in rural areas, in smokers, and in those with kidney disease (all p<0.05). Obesity also reduced glaucoma risk in people with diabetes, hypertension, or dyslipidemia more than in healthy controls (all p<0.05).CONCLUSIONS: This cohort study suggests that obesity was associated with a reduced risk of glaucoma, especially in rural residents, smokers, and people with kidney disease. Obesity exerted a stronger protective effect in people with diabetes, hypertension, or dyslipidemia than in healthy people.

23 December 2025 in American Journal of Ophthalmology
Verified
Journal Article
Open access
CHChenyue Hang
Chenyue Hang
TZTianyuan Zhao
Tianyuan Zhao
ZCZhixuan Chen
Zhixuan Chen
HWHong Wang
Hong Wang
LCLin Chen
Lin Chen
XSXiaodong Sun
Xiaodong Sun
To investigate the genotype-phenotype correlation in RHO-associated retinopathy, with a focus on delineating an ethnic-specific variant spectrum and comparing clinical severity across biological classes and common variants. Retrospective cohort study and literature review. We systematically reviewed all published cases of RHO-associated retinal diseases (2196 patients, 1278 probands) and analyzed clinical, genetic, and imaging data from our institutional cohort (80 probands). Variants were categorized by type and by biological class (Class 1-7), and phenotypes were compared across different biological classes and three common variants. A marked geographic divergence was observed: P23H was common in North America but rare in other populations, whereas P347L and R135W were major common variants in European and Asian populations. Genotype-phenotype analysis revealed that Class 2 variants were associated with later onset and slower visual decline, whereas Class 1 and Class 3 variants correlated with earlier onset (P < .0001) and more aggressive phenotypes. Notably, R135W (Class 3) emerged as an under-recognized but highly aggressive variant, with earlier onset (P < .01) and potentially earlier macular involvement. Our study represents the largest study integrating ethnic, genotypic, and clinical data in RHO-associated retinopathy. The findings highlight substantial inter-ethnic differences in common variants and underscore the clinical relevance of biological classification in predicting disease course. In particular, R135W and P347L warrants closer clinical attention due to their aggressive trajectory, which may inform prioritization in gene therapy trials and individualized patient management.

19 November 2025 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
JWJinyuan Wang
Jinyuan Wang
JLJingting Luo
Jingting Luo
SYShiyi Yin
Shiyi Yin
HZHaihan Zhang
Haihan Zhang
HZHanqing Zhao
Hanqing Zhao
WWWenbin Wei
Wenbin Wei
Purpose Visual functional testing methods are limited and cannot be well applied in all kinds of ocular diseases, especially those with low-vision. To determine whether full-field stimulus threshold (FST) is an effective method in evaluating Bietti crystalline dystrophy (BCD), with the capability in replacing other traditional visual functional methods, we designed the study. Methods This study was a prospective cross-sectional observational study, conducted from September 2022 to March 2023. It was a sub-study of Beijing Tongren Eye Disease Clinical Database Biobank. The study was conducted in Beijing Tongren Hospital, Capital Medical University. BCD patients who were diagnosed based on clinical features, validated by whole-exome sequencing were included. The normal volunteers were included as control group. All BCD patients underwent comprehensive evaluations, including FST, best-corrected visual acuity (BCVA), color vision, microperimetry, full-field electroretinography (ffERG), optical coherence tomography (OCT), multimodal imaging system and 4 self-reported questionnaires. The normal control group subjects only conducted FST examination. The correlation between FST and BCVA, and the differences of FST values between disease severity groups, were evaluated. The BCVA logistic regression model, FST model and hybrid model’s performance (area under the curve [AUC]) were tested in predicting disease severity. Results 43 BCD patients (40.60 ± 8.57 years, 22 female [51%]) and 36 normal volunteers (38.56 ± 12.42 years, 21 female [58%]) were included. FST showed a moderate correlation with BCVA scores. Stage 2 group exhibited notably lower FST values than the stage 3 group, while the severely diminished group showed remarkable lower FST values than the extinguished group. The hybrid model showed better performance (AUC = 0.9221 and 0.9496) than FST model (AUC = 0.9026 and 0.9429), better than BCVA model (AUC = 0.8549 and 0.8487) in predicting disease severity. Conclusions The FST serves as a useful indicator for evaluating visual function and predicting the severity of disease in patients with BCD. The clinical implementation of FST value will serve as an important assay in various ocular diseases, necessitating further validation studies prior to its application.

19 November 2025 in American Journal of Ophthalmology
Verified
Journal Article
Open access
YHYu Hong
Yu Hong
JLJianqing Li
Jianqing Li
ZCZhixuan Chen
Zhixuan Chen
TZTing Zhang
Ting Zhang
MCMinghao Chen
Minghao Chen
Xiaodong SunXiaodong Sun
Xiaodong Sun
To delineate the intricate interplay between inflammation, retinal remodeling, and genotype in CRB1-associated inherited retinal diseases (CRB1-IRDs). Retrospective, multicenter observational case series. We evaluated 66 CRB1-retinopathy patients from 61 unrelated families recruited from 4 tertiary hospitals in China between June 2016 and July 2024. Comprehensive medical records, ophthalmic examination and multimodal fundus imaging were obtained and reviewed. The main outcome measures included: inflammatory-like fundus characteristics, quantitative assessments of retinal thickness, and genotype-phenotype correlations regarding both inflammatory-like features and the severity of outer retinal disruption. Among 66 patients (59.1% male, aged 3-57 years), clinical diagnoses included retinitis pigmentosa (RP, 60.6%), Leber congenital amaurosis (LCA, 33.3%), and cone-rod dystrophy (6.1%). Several inflammatory-like fundus features were identified, including preserved para-arteriolar retinal pigment epithelium (PPRPE, 77.5%), yellow-white lesions (68.1%), vascular sheathing (48.9%), nummular pigmentation (26.6%) and Coats-like vasculopathy (3.2%). In CRB1-IRD retinas with residual outer nuclear layer (ONL), inner nuclear layer thickening was observed, whereas those with complete ONL loss exhibited progressive atrophy. Patients with biallelic loss-of-function variants exhibited significantly higher prevalence of PPRPE (88% vs 64.7%, P = .042), yellow-white lesions (80% vs 52.9%, P = .038), and greater outer retinal disruption compared to those with biallelic non-null mutations (outer plexiform layer continuity: 18.2% vs 50%, P = .014; ellipsoid zone retention: 13.6% vs 40%, P = .031). This study identifies retinal inflammation-like changes as core features of CRB1-IRD, might associated with retinal remodeling and genotype. These findings provide new insights into CRB1-IRD and establish references for diagnosis and future clinical trial design.